Association between inflammatory bowel disease and frailty: a two-sample Mendelian randomization study
Authors:
Open Access
- 6 February 2024
- journal article
- research article
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 36 (1) , 1-9
Abstract
Background: An association has been identified between inflammatory bowel disease (IBD) and frailty; however, the causal nature of this connection remains uncertain. We consequently conducted a two-sample Mendelian randomization (MR) analysis to explore this particular association. Methods: We acquired distinct datasets for inflammatory bowel disease (IBD), Crohn's disease (CD), ulcerative colitis (UC), and frailty from the published genome-wide association studies (GWAS) database, meticulously selecting instrumental variables (IVs). Subsequently, we employed a bidirection MR to examine the causal relationship between IBD (including CD and UC) and frailty. We utilized statistical methods, with a primary emphasis on inverse-variance weighted (IVW), accompanied by a series of sensitivity analyses to confirm heterogeneity and pleiotropy influenced the outcomes of the MR. Results: We found positive causal effects of genetically increased frailty risk on IBD (OR: 1.015, 95% CI 1.005–1.025, P = 0.004). Furthermore, when scrutinizing specific IBD subtypes, both Crohn's disease (CD) and ulcerative colitis (UC) demonstrated an increased predisposition to frailty (OR: 1.018, 95% CI 1.01–1.027, P < 0.05) and (OR = 1.016, 95% CI 1.005–1.027, P < 0.05). Nevertheless, despite the consistent trends observed in the weighted median and MR-Egger regression analyses for both conditions, statistical significance remained elusive. Notably, the results of the inverse MR analysis did not establish an association between frailty and an elevated risk of IBD development. Conclusions: Our research indicates that IBD, encompassing both CD and UC, may augment the propensity for frailty. Clinical practitioners must prioritize early frailty assessment in individuals afflicted with inflammatory bowel disease, inclusive of Crohn's disease and ulcerative colitis, facilitating proactive measures and timely interventions. However, our findings do not provide evidence supporting a causal effect of frailty on IBD (including CD and UC). Consequently, further studies are essential to explore the intricate mechanisms that clarify the effect of frailty on IBD.Keywords
Funding Information
- Postgraduate Research & Practice Innovation Program of Jiangsu Province (SJCX23_0836)
- Nanjing Health Science and Technology Development Special Funds Program (YKK19100)
This publication has 37 references indexed in Scilit:
- Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populationsNature Genetics, 2015
- Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regressionInternational Journal of Epidemiology, 2015
- Frailty syndrome: an overviewClinical Interventions in Aging, 2014
- Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized DataGenetic Epidemiology, 2013
- Reciprocal interactions of the intestinal microbiota and immune systemNature, 2012
- Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: Cross-sectional findings from the Newcastle 85+ StudyMechanisms of Ageing and Development, 2012
- Avoiding bias from weak instruments in Mendelian randomization studiesInternational Journal of Epidemiology, 2011
- Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remissionNutrition, 2008
- Design of Randomized Controlled TrialsCirculation, 2007
- Predictive Value of Whole Blood Chemiluminescence in Patients With Alcoholic HepatitisHepatology, 1990